GSK Consumer Healthcare gains after good Q2 earnings

GlaxoSmithkline Consumer Healthcare rose 2.65% to Rs 4,762 at 15:11 IST on BSE after net profit rose 14.29% to Rs 146.93 crore on 19.44% growth in total income to Rs 1057.47 crore in Q2 September 2013 over Q2 September 2012.

The Q2 result was announced during trading hours today, 6 November 2013.

Meanwhile, the S&P BSE Sensex was down 81.81 points or 0.39% at 20,892.98.

On BSE, 3,805 shares were traded in the counter as against average daily volume of 1,844 shares in the past one quarter.

The stock hit a high of Rs 4,814.30 and a low of Rs 4,641.60 so far during the day. The stock had hit a record high of Rs 6,020 on 31 May 2013. The stock had hit a 52-week low of Rs 2,980 on 12 November 2012.

The stock had underperformed the market over the past one month till 5 November 2013, advancing 6.88% compared with the Sensex's 5.32% rise. The scrip had also underperformed the market in past one quarter, surging 8.7% as against Sensex's 9.34% rise.

The large-cap company has equity capital of Rs 42.06 crore. Face value per share is Rs 10.

GlaxoSmithkline Consumer Healthcare is a leading player in the malted food drinks segment. Its major brands include Horlicks, Boost, Viva and Maltova.

Powered by Capital Market - Live News